STAT+: Pharmalittle: We’re reading about a Massachusetts biotech slump, Akeso lung cancer survival data, and more
Written by
STAT News
Published
0
comments
0
min
A new report paints a grim outlook for the Massachusetts biotech industry, as venture investment fell 17% in the first half of 2025